4826 - 4850 of 6082 Results
Title
Year
- Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys2016OPENTitle: Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated MonkeysJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 11Start Page: 1543End Page: 1551Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00186Best OA location URL: https://europepmc.org/articles/pmc5510653?pdf=renderCitation Count: 9
- Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue2016OPENTitle: Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissueJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-016-0371-yBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-016-0371-yCitation Count: 67
-
OPENTitle: Neuropsychiatric characteristics of GBA-associated Parkinson diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 370Issue #:Start Page: 63End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.08.059Best OA location URL: https://europepmc.org/articles/pmc5268078?pdf=renderCitation Count: 55
- Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer’s Disease2016OPENTitle: Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 54Issue #: 4Start Page: 1395End Page: 1408Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-160528Best OA location URL: https://europepmc.org/articles/pmc5074904?pdf=renderCitation Count: 61
- Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer’s disease2016OPENTitle: Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep32583Best OA location URL: https://www.nature.com/articles/srep32583.pdfCitation Count: 22
- Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson’s Disease and Control Subjects2016OPENTitle: Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson’s Disease and Control SubjectsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 4Start Page: 761End Page: 770Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-160888Best OA location URL: https://europepmc.org/articles/pmc5501392?pdf=renderCitation Count: 87
- Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease2016OPENTitle: Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 10Start Page: 1217End Page: 1217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2016.2245Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2546252/noi160057.pdfCitation Count: 211
- Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II‐mediated respiration2016OPENTitle: Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II‐mediated respirationJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 10Issue #: 12Start Page: 1205End Page: 1217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/prca.201600005Best OA location URL: https://europepmc.org/articles/pmc5810131?pdf=renderCitation Count: 29
-
OPENTitle: Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathiesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 10Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.338Best OA location URL: https://doi.org/10.1002/acn3.338Citation Count: 475
- Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study Protocol2016OPENTitle: Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study ProtocolJournal Name: JMIR Research ProtocolsPublisher: JMIR Publications Inc.Vol: 5Issue #: 3Start Page: e172End Page: e172Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/resprot.5990Best OA location URL: https://www.researchprotocols.org/2016/3/e172/PDFCitation Count: 64
- Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson’s disease patients2016OPENTitle: Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson’s disease patientsJournal Name: SpringerPlusPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40064-016-3110-8Best OA location URL: https://springerplus.springeropen.com/track/pdf/10.1186/s40064-016-3110-8Citation Count: 12
- Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery2016OPENTitle: Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug deliveryJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep31732Best OA location URL: https://www.nature.com/articles/srep31732.pdfCitation Count: 46
-
OPENTitle: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitorsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.17111Best OA location URL: https://doi.org/10.7554/elife.17111Citation Count: 55
- A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein2016OPENTitle: A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0125-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0125-0Citation Count: 38
- Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension2016OPENTitle: Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotensionJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-016-0665-5Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-016-0665-5Citation Count: 4
-
OPENTitle: LRRK2 deficiency impacts ceramide metabolism in brainJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 478Issue #: 3Start Page: 1141End Page: 1146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2016.08.082Best OA location URL: https://discovery.ucl.ac.uk/1508867/1/Plotegher.pdfCitation Count: 58
-
OPENTitle: Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 30Issue #: 11Start Page: 3853End Page: 3859Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.201600756rBest OA location URL: https://www.fasebj.org/doi/pdf/10.1096/fj.201600756RCitation Count: 340
- Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker2016OPENTitle: Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarkerJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep31391Best OA location URL: https://www.nature.com/articles/srep31391.pdfCitation Count: 259
-
OPENTitle: Parkinson’S Disease is Ready for Precision MedicineJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 13Issue #: 5Start Page: 405End Page: 407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0052Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0052Citation Count: 7
- Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease2016OPENTitle: Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s diseaseJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 213Issue #: 9Start Page: 1759End Page: 1778Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1084/jem.20160368Best OA location URL: https://rupress.org/jem/article-pdf/213/9/1759/1134774/jem_20160368.pdfCitation Count: 347
- Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in mice2016OPENTitle: Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in miceJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 35Issue #: 18Start Page: 2008End Page: 2025Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.201593585Best OA location URL: https://europepmc.org/articles/pmc5282834?pdf=renderCitation Count: 63
- Predictive Big Data Analytics: A Study of Parkinson’s Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations2016OPENTitle: Predictive Big Data Analytics: A Study of Parkinson’s Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete ObservationsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 8Start Page: e0157077End Page: e0157077Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0157077Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157077&type=printableCitation Count: 134
-
OPENTitle: Commentary: XBP-1 Is a Cell-Nonautonomous Regulator of Stress Resistance and LongevityJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00182Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00182/pdfCitation Count: 5
- Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synuclein2016OPENTitle: Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synucleinJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 113Issue #: 34Start Page: 9587End Page: 9592Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1610099113Best OA location URL: https://www.pnas.org/content/pnas/113/34/9587.full.pdfCitation Count: 238
-
OPENTitle: LRRK2 variation and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 31Issue #:Start Page: 98End Page: 103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.07.015Best OA location URL: https://europepmc.org/articles/pmc5048558?pdf=renderCitation Count: 38